• Home
  • Study Details
By physician referral or invitation only

A prospective study of breast milk concentration of bimekizumab in mothers taking Bimzelx® (bimekizumab)

To assess the concentration of bimekizumab in mature breast milk of breastfeeding women who are prescribed commercial bimekizumab (Bimzelx®) by their treating physician in accordance with the locally approved prescribing information.

Age & Gender

  • 18 years ~ 99 years
  • Female

Contact the Team

Location

Thank you for your interest, but this study is recruiting by invitation only.

North Carolina (Statewide)

Additional Study Information

Principal Investigator

Chris Sayed
Dermatology-Research

Study Type

Clinical or Medical
Observational

Study Topics

Women's Health

IRB Number

25-2658

Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research